Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin fMRI Pharmacodynamic Study in Cocaine and Opioid Use Disorder
NCT03143543Phase 1Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Jul 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lorcaserin in cocaine use disorder (CUD) and opioid use disorder (OUD) (4 arms), sponsored by Virginia Commonwealth University. Primary endpoint: Target engagement by lorcaserin at 7 days. Started Jul 2015; status: terminated.
02
Drugs
lorcaserin
03
Conditions
cocaine use disorder (CUD)opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03143543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03143543.